SAI LIFE SCIENCES LIMITED

11 Dec 2024 - 13 Dec 2024 Individual Category Main Board BSE NSE

Min Investment

₹28188

Price Band

₹522-₹549

Issue Size

388.3 lakhs
Equity Shares

Lot Size

27 (per lot)

IPO Dates
img

11 Dec 2024

Open Date

img

13 Dec 2024

Close Date

img

16 Dec 2024

Allotment Date

img

18 Dec 2024

Listing Date

Sai Life Sciences IPO issue size is 3.88 crore equity shares. This IPO is a combination of a fresh issue and an offer for sale. The IPO is a book-built issue type with price band of Rs 522 to 549 per share. Sai Life Sciences IPO 1 lot consists of 27 shares. The minimum investment for the retail category is to be around Rs 14,823. The allotment status will be released on Monday, December 16, 2024. The listing will be on the NSE and BSE platforms on Wednesday, December 18, 2024. Sai Life Sciences IPO registrar is Kfin Technologies Limited. On the date of allotment, Investors can visit the Kfin Technologies Limited website select the name of the company and enter their PAN number or application ID to know their allotment status.

Know Before Investing

Strengths icon

  • Sai Life Sciences IPO: End-to-end CRAMS solutions with advanced R&D and manufacturing capabilities.
  • Global presence and diverse clientele driving consistent growth.
  • Strong financial performance and strategic leadership in a high-demand market.

Weaknesses icon

  • Sai Life Sciences IPO: Dependency on key clients and strict global regulatory norms.
  • Intense competition from global and regional players.
  • Economic shifts and rising input costs may impact profitability.

About Sai Life Sciences Limited

Sai Life Sciences Limited incorporated in 1999, researches, develops, and manufactures small-molecule new chemical entities. They offer tailor made services to biotech firms and global pharma companies. By the end of Sep 2024,  Sai Life Sciences provided services to over 280 innovator pharmaceutical companies, including more than 230 in the month alone. Sai Life Sciences business development team consists of 16 experienced and qualified professionals, with six located in the US, 9 in the UK and Europe, and 1 in Japan. Sai Life Sciences competitive strength is: 1) they provide a complete platform for discovery, development, and manufacturing. 2) CRO services include integrated discovery capabilities across biology, chemistry, and drug metabolism and pharmacokinetics. 3) CDMO platform with a diverse mix of commercial and under-development molecules.

Founded

1999

Managing Director

Krishna Kanumuri

Parent Organization

IPO Objectives

The funds raised from Sai Life Sciences IPO will be used to repay the company's past borrowings. The remaining money will be used for general corporate purposes.

Company Promoters

Kanumuri Ranga Raju

Krishnam Raju Kanumuri

Kanumuri Mytrey

Sai Quest Syn Private Limited

Sunflower Partners

Lily Partners

Marigold Partners

Tulip Partners.

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 0
Non-Institutional Buyers 0
bNII (bids above ₹10L) 0
sNII (bids below ₹10L) 0
Retail Investors 0
Employees 0
Others 0
Total 0
img

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account